UroGen Pharma Ltd Capital Reinvestment Ratio
UroGen Pharma Ltd capital reinvestment ratio. UroGen Pharma Ltd (URGN) has a Capital Reinvestment Ratio of 0.01x as of September 2017, meaning it reinvests 0% of its operating cash flow ($2.60 Million) in capital expenditures ($20.00K). Check UroGen Pharma Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of UroGen Pharma Ltd (2016–2016)
Capital reinvestment ratio of UroGen Pharma Ltd from 2016 to 2016. This chart tracks UroGen Pharma Ltd's Capital Reinvestment Ratio across 1 annual periods. Also explore URGN shareholders equity momentum to track the company's year-over-year net asset growth rate.
UroGen Pharma Ltd Capital Reinvestment Ratio by Year (2016–2016)
UroGen Pharma Ltd capital reinvestment ratio by year from 2016 to 2016. For the full cash flow conversion analysis, see cash flow conversion of UroGen Pharma Ltd.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2016 | 0.17x | $4.19 Million | $695.00K | — |